Louisa Helms, is a Senior Associate at Flagship Pioneering, where she is immersed in company origination and translating cutting-edge science into transformative solutions for human health.
Her career path has been driven by her desire to connect groundbreaking science with its commercial potential. After earning her Ph.D. in Molecular Medicine and Mechanisms of Disease, she realized that she was more interested in guiding companies and shaping strategy than doing hands-on research.
While gaining entrepreneurial experience at a biotech startup, she observed a communication gap between scientists and investors. Scientists often struggled to convey the value of their innovations, while investors found it difficult to grasp the science behind them. Louisa bridged that gap by learning to communicate complex ideas in clear, accessible ways, helping diverse audiences understand the science and see its company-building possibilities. This involved applying a strategic lens to scientific concepts, business models, and operational frameworks, to create actionable roadmaps for advancement—abilities that ultimately led her to Flagship.
Louisa joined Flagship in 2022 and quickly became embedded in an early-stage company. From day one, she embraced every challenge with determination and was committed to doing whatever it takes to drive innovation and prepare the company for its next stage of growth. She has been instrumental in scaling the team from five to more than forty and has worn many hats along the way—from leading cell biology teams and advancing therapeutic workstreams to guiding corporate and intellectual property strategy.